Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laurie Stelzer currently holds 32,000 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurie Stelzer has been a net buyer of HALO stock. They have purchased $344.8K and sold $172.2K worth of shares.
Laurie Stelzer's most recent insider trade was on Jan 20, 2026, when they sold 32,000 shares at $0.00 per share.
Laurie Stelzer serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 41 insider transactions totaling $517.0K over their tenure at the company.
Laurie Stelzer holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Laurie Stelzer has shown a buying trading pattern, with $344.8K in total purchases and $172.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Laurie Stelzer was on Aug 9, 2023, when they purchased $825.0K worth of MRTX shares. This transaction involved 22,297 shares at $37.00 per share.
Laurie Stelzer currently owns 32,000 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laurie Stelzer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laurie Stelzer has 41 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Laurie Stelzer and 40,000+ other insiders.